\
&
Contact us
This was 3 weeks ago
Locationonline
ProgrammesJoin the Horizon Europe Cluster 5 info day on 15 January 2026 to explore the 2026 topics of the forthcoming work programme 2026-2027. This online event will be streamed via the European Commission’s web platform.
What to expect
Insights into the policy context
Guidance for preparing a high-quality proposal
Tips for enhancing the role of Social Sciences and Humanities in relevant topics
Interactive parallel sessions by thematic area to address specific questions on the topics
Here you can find more information on the event and register
The official publication of the Cluster 5 work programme 2026-2027 is expected any day now (estimated budget of €1.2 billion for the 2026 calls). A pre-publication version is already available.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.